RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: allergic contact dermatitis
Accession: DOID:3042
browse the term
Definition: A contact dermatitis that is an allergic skin reaction to foreign chemical or substances leading to red, itchy, weepy reaction where the skin has come into contact with a substance that the immune system recognizes as foreign. (DO)
Synonyms: exact_synonym: Allergic Contact Dermatitides; Allergic Eczematous Dermatitides; Allergic Eczematous Dermatitis
primary_id: MESH:D017449
xref: EFO:1000668 ; ICD10CM:L23 ; ICD10CM:L23.9 ; NCI:C26998
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abca6
ATP binding cassette subfamily A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
G
Asrgl1
asparaginase and isoaspartyl peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:206,006,103...206,027,115
Ensembl chr 1:206,006,109...206,027,108
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bmp6
bone morphogenetic protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Calcrl
calcitonin receptor like receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
G
Casp8
caspase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccl17
C-C motif chemokine ligand 17
ISO
RGD
PMID:15491423
RGD:1626251
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl19
C-C motif chemokine ligand 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:ear (mouse)
RGD
PMID:15491423
RGD:1626251
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr1
C-C motif chemokine receptor 1
ISO
RGD
PMID:18844696
RGD:5688176
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17374397 PMID:10899907
RGD:8661227
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:22075493
RGD:6892916
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:skin, lymph node (rat)
RGD
PMID:16977379
RGD:2325935
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd3d
CD3 delta subunit of T-cell receptor complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
G
Cidec
cell death-inducing DFFA-like effector c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
G
Cish
cytokine inducible SH2-containing protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Cntn3
contactin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613
G
Crem
cAMP responsive element modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Ctsc
cathepsin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23178550
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:19022366
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Emb
embigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
G
Ets2
ETS proto-oncogene 2, transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
F13a1
coagulation factor XIII A1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
G
Fgl2
fibrinogen-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
mRNA:protein:skin:
RGD
PMID:7876550
RGD:7421586
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fyb1
FYN binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
G
Grk2
G protein-coupled receptor kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Ifi30
IFI30, lysosomal thiol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:12484431 PMID:15347381
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igsf6
immunoglobulin superfamily, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:175,610,167...175,620,662
Ensembl chr 1:175,610,167...175,620,722
G
Il10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15347381 PMID:23760007
RGD:7364806
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
treatment
ISO
mRNA:increased expression:skin CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27585668 PMID:9781803 PMID:12874202
RGD:8655902 , RGD:8655940
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
treatment
ISO
RGD
PMID:12874202
RGD:8655940
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23178550
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:22245253
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12484431 PMID:21804303
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15347381
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Ipcef1
interaction protein for cytohesin exchange factors 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
G
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Jam2
junctional adhesion molecule 2
ISO
RGD
PMID:16297198
RGD:7488919
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
G
Jam3
junctional adhesion molecule 3
ISO
RGD
PMID:16297198
RGD:7488919
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Kdr
kinase insert domain receptor
ISO
mRNA:protein:skin:
RGD
PMID:7876550
RGD:7421586
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kmo
kynurenine 3-monooxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Mc1r
melanocortin 1 receptor
ISO
RGD
PMID:20126537
RGD:5687319
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Meox1
mesenchyme homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Mir155
microRNA 155
treatment
IEP
RGD
PMID:29404871
RGD:21079472
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
treatment
IEP
RGD
PMID:29282578
RGD:41404666
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mki67
marker of proliferation Ki-67
ISO
RGD
PMID:21294775
RGD:6483538
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp3
matrix metallopeptidase 3
IEP ISO
mRNA:increased expression:skin, lymph node
RGD
PMID:16977379 PMID:10359808
RGD:2325935 , RGD:8693317
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
IEP ISO
mRNA:increased expression:skin, lymph node
RGD
PMID:16977379 PMID:10359808 PMID:10415717
RGD:2325935 , RGD:8693317 , RGD:8547869
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mrc1
mannose receptor, C type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Mxd1
max dimerization protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Nampt
nicotinamide phosphoribosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nat1
N-acetyltransferase 1
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:19663877
RGD:8552666
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16533241
RGD:8552663
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23564646
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ninj1
ninjurin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Numa1
nuclear mitotic apparatus protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:156,297,907...156,372,855
Ensembl chr 1:156,326,259...156,372,855
G
Ogg1
8-oxoguanine DNA glycosylase
ISO
RGD
PMID:15677345
RGD:8657146
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Phlda1
pleckstrin homology-like domain, family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Prdx4
peroxiredoxin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr X:40,026,762...40,044,066
Ensembl chr X:40,026,651...40,044,066
G
Qpct
glutaminyl-peptide cyclotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 6:15,964,656...15,996,730
Ensembl chr 6:15,964,657...15,996,711
G
Rab32
RAB32, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rgs1
regulator of G-protein signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Sat1
spermidine/spermine N1-acetyl transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Slc2a3
solute carrier family 2 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc7a5
solute carrier family 7 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs2
suppressor of cytokine signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14555839
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
G
Stac
SH3 and cysteine rich domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 8:111,530,800...111,653,228
Ensembl chr 8:111,530,800...111,654,008
G
Tap2
transporter 2, ATP binding cassette subfamily B member
susceptibility
ISO
RGD
PMID:9303338
RGD:6482276
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:20711192 PMID:18725520
RGD:7777133 , RGD:7794737
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr7
toll-like receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr X:27,027,380...27,054,309
Ensembl chr X:27,027,425...27,054,754
G
Tmsb10
thymosin, beta 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15849067
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404 PMID:17374397
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tslp
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:30187507
RGD:38596345
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Upp1
uridine phosphorylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Vegfa
vascular endothelial growth factor A
IEP ISO
mRNA:protein:skin:
RGD
PMID:7876550 PMID:7876550
RGD:7421586 , RGD:7421586
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Actl9
actin-like 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 7:14,234,504...14,235,881
Ensembl chr 7:14,234,504...14,235,881
G
Adam17
ADAM metallopeptidase domain 17
ISS
OMIM:603165
MouseDO
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Apoe
apolipoprotein E
ISO
protein:decreased expression:plasma
RGD
PMID:19116453
RGD:11040546
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Artn
artemin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
G
Bdnf
brain-derived neurotrophic factor
susceptibility no_association
ISO
DNA:polymorphism::C270T(human) mRNA:decreased expression:mast cell DNA:polymorphism:cds:p.V66M(human) protein:increased expression:serum:
RGD
PMID:19522715 PMID:17845420 PMID:19038326 PMID:17073871
RGD:8657028 , RGD:8657065 , RGD:8657067 , RGD:8657069
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
C3
complement C3
ISO
protein:increased expression:plasma
RGD
PMID:3923750
RGD:7401273
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Card11
caspase recruitment domain family, member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114 PMID:28628108
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Casp8
caspase 8
ISS
OMIM:603165
MouseDO
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccdc80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
G
Ccl11
C-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl17
C-C motif chemokine ligand 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl20
C-C motif chemokine ligand 20
severity treatment
ISO
protein:increased expression:plasma
RGD
PMID:11133838 PMID:19162238
RGD:7483580 , RGD:7483583
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437 PMID:22125604
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl24
C-C motif chemokine ligand 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl26
C-C motif chemokine ligand 26
ISO
protein:increased expression:serum (human)
RGD
PMID:14616792
RGD:11087554
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
G
Ccl27
C-C motif chemokine ligand 27
ISO
RGD
PMID:12642842
RGD:1626250
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
G
Ccl28
C-C motif chemokine ligand 28
severity
ISO
associated with Asthma; protein: increased secretion:serum (human)
RGD
PMID:20161852
RGD:4892193
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
G
Ccl5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr2
C-C motif chemokine receptor 2
ISO
protein:increased expression:skin,monocyte:
RGD
PMID:15370700
RGD:8661734
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
ISO
protein:increased expression:skin CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:16449815
RGD:6893391
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:16449815
RGD:6893391
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd40
CD40 molecule
ISO
RGD
PMID:18693155
RGD:5132274
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cdsn
corneodesmosin
ISO
protein:decreased expression:skin of body (human)
RGD
PMID:21211653
RGD:42721970
NCBI chr20:3,179,432...3,184,252
Ensembl chr20:3,179,438...3,184,250
G
Cldn1
claudin 1
ISO
mRNA,protein:decreased expression:epidermis; DNA:SNPs:intron,promoter :rs17501010,rs9290927,rs893051,rs9290929,rs16865373(human)
RGD
PMID:21163515
RGD:11344875
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn23
claudin 23
ISO
mRNA:decreased expression:epidermis:
RGD
PMID:21163515
RGD:11344875
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
G
Cma1
chymase 1
ISO
DNA:polymorphism:5' utr:g.-1903G>A rs1800875 (human)
RGD
PMID:16134991
RGD:1625394
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNP,haplotype:exon,3'UTR:rs3087243,rs231775 (human) mRNA:increased expression:blood:
RGD
PMID:16445777 PMID:22357516
RGD:7411698 , RGD:7411700
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Ctse
cathepsin E
ISS
OMIM:603165
MouseDO
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:serum
RGD
PMID:15131578
RGD:9491761
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
protein:decreased expression:blood, leukocyte
RGD
PMID:24821910 PMID:15131578
RGD:9491393 , RGD:9491761
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
ISO
ClinVar Annotator: match by term: Atopic eczema
ClinVar
PMID:25741868
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Dock8
dedicator of cytokinesis 8
ISO
DNA:mutations:cds:
RGD
PMID:22476911
RGD:40903056
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
G
Emsy
EMSY transcriptional repressor, BRCA2 interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 1:152,881,485...152,960,420
Ensembl chr 1:152,883,992...152,953,528
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:plasma
RGD
PMID:21488867
RGD:5147756
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fcgr2a
Fc gamma receptor 2A
severity
ISO
protein:increased expression:eosinophil
RGD
PMID:7564170 PMID:19414806
RGD:5147985 , RGD:5508430
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Flg
filaggrin
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Atopic eczema
CTD ClinVar
PMID:3163778 PMID:16444271 PMID:16550169 PMID:16815158 PMID:17030239 PMID:18325573 PMID:19349982 PMID:19501237 PMID:19839980 PMID:19874431 PMID:21514438 PMID:22403702 PMID:23042114 PMID:23348739 PMID:23947670 PMID:24033266 PMID:24061166 PMID:24920311 PMID:25741868 PMID:27279822 PMID:27363669 PMID:31637781 More...
NCBI chr 2:178,884,793...178,912,986
G
Glb1
galactosidase, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:21176116 PMID:20674822
RGD:5490539 , RGD:5490981
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:19842992 PMID:20674822
RGD:5490540 , RGD:5490981
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
ISO
DNA:deletion, haplotype: :
RGD
PMID:19842992
RGD:5490540
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:16159638
RGD:5128852
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hnmt
histamine N-methyltransferase
ISO
RGD
PMID:19025430
RGD:5128889
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:33274957 PMID:22101570
RGD:8157618
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifnl3
interferon, lambda 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22295096
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
G
Il10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:23843958
RGD:7364805
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
severity treatment
ISO ISS
DNA:SNPs: :rs3091307, rs20541 (human) DNA, protein:SNP, increased expression:promoter, serum:-1112C>T (human) DNA:SNP:exon:4257G>A (human) CTD Direct Evidence: marker/mechanism OMIM:603165
CTD MouseDO RGD
PMID:18249437 PMID:22355542 PMID:21913997 PMID:23317483 PMID:10887320 PMID:19006098 PMID:17313488 PMID:16672002 More...
RGD:5684364 , RGD:8549509 , RGD:8549529 , RGD:8549531 , RGD:8549539 , RGD:8549583
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra1
interleukin 13 receptor subunit alpha 1
ISO
mRNA:increased expression:skin
RGD
PMID:14527737
RGD:8549525
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
protein:increased expression:serum
RGD
PMID:21462799 PMID:20971924
RGD:8549521 , RGD:8549556
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il17a
interleukin 17A
treatment severity
ISO
protein:increased expression:epidermis (mouse) protein:increased expression:dermis, lymphocyte (human)
RGD
PMID:24337738 PMID:22848348 PMID:18432274
RGD:8698670 , RGD:9068417 , RGD:9068436
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
severity no_association
ISO ISS
protein:increased expression:serum DNA:SNPs, haplotype: :rs795467, rs4937113, rs5744247 (human) DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human) OMIM:603165
MouseDO RGD
PMID:15317323 PMID:17517100 PMID:11490156 PMID:22840759 PMID:22840759
RGD:8655872 , RGD:8655876 , RGD:8655908 , RGD:8655914 , RGD:8655914
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
susceptibility
ISO
associated with food hypersensitivity; DNA:SNP:promoter:rs2069762(human) protein:increased expression:CD8+ T cell:
RGD
PMID:7547077 PMID:21982597 PMID:16333313 PMID:16672002 PMID:1673687
RGD:8662961 , RGD:8663444 , RGD:8663473 , RGD:8549583 , RGD:8693325
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il21r
interleukin 21 receptor
ISO
protein:increased expression:skin
RGD
PMID:19075398 PMID:19075398
RGD:6892938 , RGD:6892938
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
G
Il23a
interleukin 23 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33274957
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il25
interleukin 25
ISO
protein:increased expression:arm skin
RGD
PMID:23657503
RGD:39128244
NCBI chr15:28,408,766...28,412,157
Ensembl chr15:28,408,842...28,411,893
G
Il31
interleukin 31
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr12:33,095,108...33,105,026
Ensembl chr12:33,092,097...33,105,037
G
Il33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
ISO ISS
DNA:SNP:promoter:-590C>T (human) protein:increased expression:serum CTD Direct Evidence: marker/mechanism OMIM:603165
CTD MouseDO RGD
PMID:11886533 PMID:12230500 PMID:18249437 PMID:9643293 PMID:8363440
RGD:7829786 , RGD:7829795
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
susceptibility
ISO
DNA:mutation:cds:p.Q576R(human)
RGD
PMID:9392697
RGD:11530001
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il5
interleukin 5
ISO
mRNA: increased expression: skin CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11886533 PMID:18249437 PMID:33274957 PMID:22299064
RGD:5687175
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
ISO
ClinVar Annotator: match by term: Atopic eczema
ClinVar
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Mapk8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24046278
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphisms:promoter, exon:
RGD
PMID:20642202
RGD:8693720
NCBI chr 1:228,016,439...228,024,736
G
Mc1r
melanocortin 1 receptor
ISO
protein: increased expression: skin
RGD
PMID:19889022
RGD:5687321
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:27776525
RGD:13204759
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Ms4a2
membrane spanning 4-domains A2
susceptibility
ISO
Atopy and bronchial hyperresponsiveness, OMIM:147050 Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G
RGD
PMID:8817330 PMID:8817330
RGD:1599903 , RGD:1599903
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
G
Nat2
N-acetyltransferase 2
susceptibility no_association
ISO
DNA:polymorphisms: :481C>T, 590G>A(human) DNA:polymorphisms: :481C>T,590G>A,857G>A(human)
RGD
PMID:16224574 PMID:14528063
RGD:8552664 , RGD:8552668
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfkbia
NFKB inhibitor alpha
ISS
OMIM:603165
MouseDO
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbiz
NFKB inhibitor zeta
ISS
OMIM:603165
MouseDO
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Ngf
nerve growth factor
ISO
protein:increased expression:serum:
RGD
PMID:17073871
RGD:8657069
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:nerve fibers of the papillary dermis (human)
RGD
PMID:16586073
RGD:5508452
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
protein:increased expression:eosinophil
RGD
PMID:18647313 PMID:17223862
RGD:5144116 , RGD:5684771
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Ovol1
ovo like transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
potential therapeutic target with or without glucocorticoid therapy (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:21633371
RGD:5509940
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppia
peptidylprolyl isomerase A
ISO
mRNA:increased expression:zone of skin (human)
RGD
PMID:32496587
RGD:150383342
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO ISS
OMIM:603165
MouseDO RGD
PMID:10940923
RGD:7777149
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
S100a8
S100 calcium binding protein A8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18336422
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12410700
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selp
selectin P
ISO
atopy and bronchial hyperresponsiveness, OMIM:147050
RGD
PMID:12929084
RGD:1599904
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Sharpin
SHANK-associated RH domain interactor
ISS
OMIM:603165
MouseDO
NCBI chr 7:108,070,681...108,075,012
Ensembl chr 7:108,070,687...108,074,955
G
Shoc2
SHOC2 leucine-rich repeat scaffold protein
ISO
associated with Noonan syndrome and related diseases; DNA:mutation:cds:c.4A>G (p.S2G)(human)
RGD
PMID:20882035
RGD:11071178
NCBI chr 1:252,958,939...253,048,820
Ensembl chr 1:252,959,723...253,047,337
G
Slc11a1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16597321
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Stat6
signal transducer and activator of transcription 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15306842
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Tgfb1
transforming growth factor, beta 1
ISO
GAD RGD
PMID:15118671 PMID:11496247
RGD:1331525 , RGD:7394812
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
severity
ISO
DNA:polymorphism: :-16934A>T(human) DNA:polymorphism:cds:p.R753Q(human)
RGD
PMID:19627277 PMID:17531301 PMID:22032785
RGD:8552997 , RGD:8552999 , RGD:8553048
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
DNA:polymorphism: :896G>A(human) mRNA:increased expression:blood cell:
RGD
PMID:23821954 PMID:19764566
RGD:7794689 , RGD:7794745
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tmem79
transmembrane protein 79
ISS
OMIM:603165
MouseDO
NCBI chr 2:173,798,267...173,803,151
Ensembl chr 2:173,798,267...173,803,046
G
Tnf
tumor necrosis factor
susceptibility
ISO
DNA:haplotype:promoter:−308G>A,-238G>A(human)
RGD
PMID:22533231
RGD:7401246
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
mRNA:altered expression:fibroblast
RGD
PMID:16650051
RGD:7777183
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Traf3ip2
Traf3 interacting protein 2
ISS
OMIM:603165
MouseDO
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
ISS
OMIM:603165
MouseDO
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Tslp
thymic stromal lymphopoietin
treatment
ISO ISS
CTD Direct Evidence: marker/mechanism OMIM:603165
CTD MouseDO RGD
PMID:16880407 PMID:22355542 PMID:23688403 PMID:27869817 PMID:29310423
RGD:38549374
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Vdr
vitamin D receptor
severity no_association
ISO
DNA:SNPs, haplotype: :rs731236, rs1544410, rs7975232 (human) DNA:SNP: :rs2228570 (human)
RGD
PMID:23034014 PMID:23034014
RGD:8157625 , RGD:8157625
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vnn1
vanin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19322213
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Wasl
WASP like actin nucleation promoting factor
ISS
OMIM:603165
MouseDO
NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:53,083,536...53,132,022
G
Flg
filaggrin
susceptibility
ISO ISS
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Dermatitis, atopic, 2 | ClinVar Annotator: match by term: Dermatitis, atopic, 2, susceptibility to OMIM:605803
CTD OMIM ClinVar MouseDO
PMID:3163778 PMID:16444271 PMID:16550169 PMID:16815158 PMID:17030239 PMID:17291859 PMID:17417636 PMID:18325573 PMID:18396323 PMID:19183181 PMID:19501237 PMID:19785597 PMID:19839980 PMID:19874431 PMID:20674819 PMID:21039602 PMID:21377035 PMID:21514438 PMID:22403702 PMID:22407025 PMID:22951058 PMID:22995991 PMID:23039796 PMID:23301728 PMID:23947670 PMID:24033266 PMID:24077912 PMID:24565632 PMID:24608987 PMID:24920311 PMID:25314673 PMID:25741868 PMID:26451970 PMID:27279822 PMID:27363669 PMID:28143684 PMID:29428354 PMID:29444371 PMID:29791750 PMID:30665703 PMID:31365035 PMID:31637781 PMID:32066784 More...
NCBI chr 2:178,884,793...178,912,986
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
disease
18969
sensory system disease
6961
skin disease
3968
dermatitis
483
contact dermatitis
246
allergic contact dermatitis
168
1,4-phenylenediamine allergic contact dermatitis
0
1-chloro-2,4-dinitrobenzene allergic contact dermatitis
0
2,4-dinitrophenyl allergic contact dermatitis
0
2-Hydroxyethyl Methacrylate Sensitization
0
4-tert-butylphenol allergic contact dermatitis
0
N,N'-diethylthiourea allergic contact dermatitis
0
N,N'-diphenylthiourea allergic contact dermatitis
0
allergic contact dermatitis of eyelid
0
atopic dermatitis +
101
benzo[d]isothiazol-3-one allergic contact dermatitis
0
benzoic acid allergic contact dermatitis
0
carvone allergic contact dermatitis
0
chromium allergic contact dermatitis
0
cobalt allergic contact dermatitis
0
diphenylmethane-4,4'-diisocyanate allergic contact dermatitis
0
formaldehyde allergic contact dermatitis
0
neomycin sulfate allergic contact dermatitis
0
nickel allergic contact dermatitis
0
palladium allergic contact dermatitis
0
parthenolide allergic contact dermatitis
0
photoallergic dermatitis +
0
potassium dichromate allergic contact dermatitis
0
toxicodendron dermatitis
0
Path 2
disease
18969
disease of anatomical entity
18249
nervous system disease
14091
Neurologic Manifestations
10055
sensory system disease
6961
skin disease
3968
Eczematous Skin Diseases
267
contact dermatitis
246
allergic contact dermatitis
168
1,4-phenylenediamine allergic contact dermatitis
0
1-chloro-2,4-dinitrobenzene allergic contact dermatitis
0
2,4-dinitrophenyl allergic contact dermatitis
0
2-Hydroxyethyl Methacrylate Sensitization
0
4-tert-butylphenol allergic contact dermatitis
0
N,N'-diethylthiourea allergic contact dermatitis
0
N,N'-diphenylthiourea allergic contact dermatitis
0
allergic contact dermatitis of eyelid
0
atopic dermatitis +
101
benzo[d]isothiazol-3-one allergic contact dermatitis
0
benzoic acid allergic contact dermatitis
0
carvone allergic contact dermatitis
0
chromium allergic contact dermatitis
0
cobalt allergic contact dermatitis
0
diphenylmethane-4,4'-diisocyanate allergic contact dermatitis
0
formaldehyde allergic contact dermatitis
0
neomycin sulfate allergic contact dermatitis
0
nickel allergic contact dermatitis
0
palladium allergic contact dermatitis
0
parthenolide allergic contact dermatitis
0
photoallergic dermatitis +
0
potassium dichromate allergic contact dermatitis
0
toxicodendron dermatitis
0